Vivek Subbiah, MD
@viveksubbiah.bsky.social
Early Phase Drug Development; Oncologist; Precision Medicine; Phase 1 trials; AI & Precision Oncology; Clinical trials. Posts=My own
Reposted by Vivek Subbiah, MD
2. Need structured approaches for how to evaluate even when an ultra-specific histology driven approach isn't feasible, as @viveksubbiah.bsky.social outlines for rare cancers here: ascopubs.org/doi/10.1200/...
Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare Cancers | JCO Oncology Practice
ascopubs.org
October 28, 2025 at 1:04 AM
2. Need structured approaches for how to evaluate even when an ultra-specific histology driven approach isn't feasible, as @viveksubbiah.bsky.social outlines for rare cancers here: ascopubs.org/doi/10.1200/...